Home › Funds › Farrow Financial, Inc. › CRSP

Farrow Financial, Inc. position in CRSP

CRISPR THERAPEUTICS AG · Health Care

Farrow Financial, Inc. reported holding 19,642 shares of CRSP (CRISPR THERAPEUTICS AG) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.58% of its reported portfolio and ranking #39 among its reported holdings. Farrow Financial, Inc. has disclosed CRSP holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)19.64K sh
Reported value held$1.09M
Portfolio Weight0.58%
First reportedQ4 2023
Last changeHold
Updated2026-10-30

Last updated: 2026-10-30 · Source: SEC EDGAR Form 13F-HR

How Farrow Financial, Inc.'s CRSP position evolved

Farrow Financial, Inc. first disclosed a stake in CRSP in Q4 2023 at 18,920 shares (US$1.2M). Across 12 filings, Farrow Financial, Inc. increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 19,642 shares valued at US$1.1M.

Quarter by quarter

QuarterSharesValueChange
Q4 2023 18.92K $1.18M New
Q1 2024 17.02K $1.16M Reduce
Q2 2024 17.36K $937.61K Add
Q3 2024 19.83K $931.47K Add
Q4 2024 20.10K $776.75K Add
Q1 2025 17.36K $590.62K Reduce
Q2 2025 17.21K $837.19K Reduce
Q3 2025 16.70K $1.08M Reduce
Q4 2025 16.13K $845.86K Reduce
Q1 2026 16.98K $807.69K Add
Q2 2026 19.64K $1.07M Add
Q3 2026 19.64K $1.09M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRSP and 13F data

CRSP (CRISPR THERAPEUTICS AG) is a Health Care company. 32 other funds we track also report a position in CRSP — the largest reported positions include ARK Invest (US$516.0M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$175.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRSP

All CRSP fund holders →

FAQ

How long has Farrow Financial, Inc. held CRSP?

Farrow Financial, Inc. has disclosed CRSP holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Farrow Financial, Inc.'s current position in CRSP?

As of Q3 2026, Farrow Financial, Inc. holds 19.64K shares of CRSP (CRISPR THERAPEUTICS AG), valued at $1.09M, representing 0.58% of its reported portfolio and ranking #39.

Has Farrow Financial, Inc. been buying or selling CRSP?

In the latest 13F filing (Q3 2026), Farrow Financial, Inc. held unchanged its position in CRSP.

Which other funds hold CRSP?

Other major institutional holders of CRSP include ARK Invest, Orbis Allan Gray Ltd, GSK plc, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.